Indraprastha Medical Corporation Limited

Healthcare · Healthcare Services

NSE: INDRAMEDCO BSE: 532150
₹348.95
▼ -5.85 (-1.65%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
87/100
Strong
Valuation
63/100
Fairly Valued
Momentum
13/100
Bearish

QVM read Quality business Quality Strong, Valuation Fairly Valued, Momentum Bearish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹3,199 Cr
PE (TTM)
17.0
Industry median 50.2 (44 companies)
Price to Book
4.3
PEG (TTM)
1.4
Institutions holding %
3.36%
FII + DII, latest filed period
Piotroski Score
4
Relative return vs Nifty50, qtr %
-2.8
Relative return vs Sector, qtr %
-7.0
Free Cash Flow
₹108 Cr
as of March 31, 2026
Industry median ₹1 Cr (75 companies)
EPS Growth (YoY)
8.56%
as of June 30, 2026
Industry median 13.27% (57 companies)
Net Profit Growth (TTM)
12.12%
as of June 30, 2026
Industry median 7.21% (57 companies)
Operating Revenue Growth (TTM)
10.92%
as of June 30, 2026
Industry median 12.82% (57 companies)
Profit Growth (YoY)
8.53%
as of June 30, 2026
Industry median 8.53% (57 companies)
Revenue Growth (YoY)
11.26%
as of June 30, 2026
Industry median 18.84% (52 companies)
Current Ratio
2.46
as of March 31, 2026
Industry median 2.06 (74 companies)
Debt to Equity
0.00
as of March 31, 2026
Industry median 0.11 (62 companies)
Interest Coverage
42.33
as of June 30, 2026
Industry median 7.94 (57 companies)
Net Margin
13.75%
as of June 30, 2026
Industry median 9.88% (61 companies)
Operating Margin (EBIT)
18.83%
as of June 30, 2026
Industry median 17.21% (61 companies)
Operating Margin (TTM)
16.98%
as of June 30, 2026
Industry median 16.20% (59 companies)
Return on Assets
18.52%
as of March 31, 2026
Industry median 5.40% (58 companies)
Return on Capital Employed
30.67%
as of March 31, 2026
Industry median 10.44% (56 companies)
Return on Equity
24.80%
as of March 31, 2026
Industry median 10.16% (58 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

6 of 8 met
  • Yes Net profit is higher than a year earlier in each of the last 4 quarters
  • Yes Revenue is higher than a year earlier in each of the last 4 quarters
  • Yes Quality score is Strong (70 or more)
  • No Piotroski F-score is 7 or more (score 4)
  • Yes Debt to equity is below 0.5 (0.00)
  • Yes Return on equity is 15% or more (24.8%)
  • No Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

3 of 3 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

0 of 3 met
  • No 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

1 of 6 met
  • Yes Price sits in the Buy zone of its own historical PE range (Buy Zone)
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-1.6%
Low 340.2000 · High 358.9500
1W return
-6.8%
Low 340.2000 · High 378.8000
1M return
-3.9%
Low 340.2000 · High 379.9500
52W return
-23.4%
Low 340.2000 · High 640.8500
Lifetime High ₹622.8000 (Nov. 6, 2025)
Lifetime Low ₹5.0000 (Oct. 15, 1998)

Full price history and technicals →

EMA & SMA

Bullish0
Bearish6
5D
357.2
10D
359.8
20D
361.3
50D
366.3
100D
374.9
200D
393.1

Delivery and volume

Day avg. delivery
54.1%
Week avg. delivery
65.1%
Month avg. delivery
60.9%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

349.37
Pivot
First resistance358.53
Second resistance368.12
Third resistance377.28
First support339.78
Second support330.62
Third support321.03
Day RSI38.9
Day MFI49.3
Day MACD-2.03
Day MACD signal-1.59

Beta

1M0.80
3M0.54
1Y1.20
3Y1.19

Price change analysis

↓ -3.9%
Over 1 Month
LowHigh
340.20379.95
↓ -9.7%
Over 3 Months
LowHigh
340.20405.90
↓ -12.7%
Over 6 Months
LowHigh
340.20444.00
↓ -23.4%
Over 1 Year
LowHigh
340.20640.85
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 17.0 (own history: 12.7–31.7)
Buy Zone
Revenue (June 30, 2026)
₹406 Cr
Net profit (June 30, 2026)
₹56 Cr
Basic EPS (June 30, 2026)
₹6.0900

Ranks #23 of 62 in Healthcare Services by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter51.00%
  • Mutual funds0.01%
  • FII/FPI2.77%
  • Other DII0.58%
  • Public45.64%

Largest holders

NameCategoryShares %Shares
PRESIDENT OF INDIAPromoter26.0000%23834196
APOLLO HOSPITALS ENTERPRISES LIMITEDPromoter22.0200%20190740
Vanaja Sundar IyerPublic1.9700%1805333
Emedlife Insurance Broking Services LimitedPublic1.7000%1557411
WEDGEWOOD HOLDINGS LIMITEDPromoter1.6100%1475000

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 51.00% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings increased from 2.44% to 2.77% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings were unchanged at 0.01% in Jun 2026 qtr

All shareholding details →

Insider trading, SAST & pledges

All 0 insider trades, 4 SAST, 0 pledge events →

All insider and SAST disclosures →

DateClientDealActionQuantityPriceExchange
8 Oct 2025 GRAVITON RESEARCH CAPITAL LLP Bulk Buy 1,232,834 587.0700 NSE
8 Oct 2025 GRAVITON RESEARCH CAPITAL LLP Bulk Sell 1,232,350 586.9800 NSE
7 Oct 2025 SWAY FINANCIAL SERVICES Bulk Buy 487,634 555.2600 NSE
7 Oct 2025 SWAY FINANCIAL SERVICES Bulk Sell 9,294 512.5300 NSE
7 Aug 2024 GRAVITON RESEARCH CAPITAL LLP Bulk Buy 541,765 327.0600 NSE
7 Aug 2024 GRAVITON RESEARCH CAPITAL LLP Bulk Sell 541,765 327.4200 NSE
22 Apr 2024 QUANT MUTUAL FUND - QUANT SMALL CAP FUND Bulk Buy 550,000 249.5900 NSE
9 Jun 2021 GRAVITON RESEARCH CAPITAL LLP Bulk Sell 707,868 99.6900 NSE
9 Jun 2021 GRAVITON RESEARCH CAPITAL LLP Bulk Buy 707,868 99.6900 NSE
7 Jun 2021 GRAVITON RESEARCH CAPITAL LLP Bulk Sell 483,819 96.5600 NSE

All bulk and block deals →

Last 12 months ₹4.00 per share
Dividend yield 1.15%
Ex-dateSubjectPer share (₹)Record date
— Final Dividend - Rs. - 4.0000 — —
18 Sep 2026 Dividend - Rs 4 Per Share 4.0000 18 Sep 2026
18 Sep 2025 Dividend - Rs 4.50 Per Share 4.5000 18 Sep 2025
13 Sep 2024 Annual General Meeting/Dividend - Rs 4.50 Per Share 4.5000 —
15 Sep 2023 Annual General Meeting/Dividend - Rs 3 Per Share 3.0000 —
15 Sep 2022 Annual General Meeting/Dividend - Rs 2.50 Per Share 2.5000 —
12 Sep 2019 Annual General Meeting/Dividend - Rs 1.60 Per Sh 1.6000 —
12 Sep 2018 Annual General Meeting/Dividend- Rs 1.50 Per Share 1.5000 —
14 Sep 2017 Annual General Meeting/Dividend - Rs 1.80 Per Share 1.8000 —
18 Aug 2016 Annual General Meeting/ Dividend - Rs 1.80/- Per Share 1.8000 —

Corporate Actions

Full history (23 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
16 Sep 2021OTHER Annual General Meeting
17 Sep 2020OTHER Annual General Meeting

All corporate actions →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
6 Aug 2026 Financial Results Yes
12 May 2026 Financial Results/Dividend Yes
3 Feb 2026 Financial Results Yes
1 Nov 2025 Financial Results Yes
6 Aug 2025 Financial Results Yes

Corporate Announcements

All 443 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
25 Sep 2026 Shareholders meeting Indraprastha Medical Corporation Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 24, 2026. Further, the company has informed the Exchange regarding voting results.
25 Sep 2026 AGM/EGM Indraprastha Medical Corporation Ltd - 532150 - AGM On 24Th September, 2026-Voting Results And Consolidated Report Of Srutinizer
24 Sep 2026 Shareholders meeting Indraprastha Medical Corporation Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 24, 2026
22 Sep 2026 Trading Window Indraprastha Medical Corporation Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
15 Sep 2026 Company Update Indraprastha Medical Corporation Ltd - 532150 - Announcement under Regulation 30 (LODR)-Newspaper Publication
15 Sep 2026 Copy of Newspaper Publication Indraprastha Medical Corporation Limited has informed the Exchange about Copy of Newspaper Publication
3 Sep 2026 Copy of Newspaper Publication Indraprastha Medical Corporation Limited has informed the Exchange about Copy of Newspaper Publication
1 Sep 2026 Shareholders meeting Indraprastha Medical Corporation Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 24, 2026
29 Aug 2026 Record Date Indraprastha Medical Corporation Limited has informed the Exchange that Record date for the purpose of Dividend is 18-Sep-2026.
29 Aug 2026 General Updates Indraprastha Medical Corporation Limited has informed the Exchange about General Updates

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Low financial leverage (Debt/Equity 0.00)
  • Comfortable interest coverage (42.3x)
  • Healthy liquidity (Current Ratio 2.46)

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

  • Down 23.4% over the past year

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Indraprastha Medical Corporation Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.